Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Effective treatments for severe alopecia areata are still lacking.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

A specific gene change is linked to severe hair loss.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.